Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Doherty: Assessing the new Medicare prescription drug law. (0.11 sec) 

Assessing the new Medicare prescription drug law

- annals.org
RB Doherty - Annals of internal medicine, 2004 - Am Coll Physicians
The Medicare Modernization Act (MMA) is the product of a political compromise to
attract moderate Republicans and enough Democrats without losing Republican
conservatives. The compromise offered more private health plans to ...
Cited by 23 - Related articles - BL Direct - All 6 versions

[CITATION] Assessing the New Medicare Prescription Drug Law


MP Plans - Ann Intern Med, 2004
Related articles

[CITATION] The implications of choice: prescribing generic or preferred formulary medications …


WH Shrank, T Hoang, SL Ettner, P Glassman, … - Arch Intern Med, 2006
Cited by 12 - Related articles

Effect of incentive-based formularies on drug utilization and spending


WH Shrank, LG Sandy, T Heady - N Engl J Med, 2004 - journal.shouxi.net
Three-tiered pharmaceutical benefits are based on the assumption that physicians
can serve as agents for their patients and prescribe the least expensive among
similarly effective formulary options. But the average physician sees ...
Cited by 7 - Related articles - Cached - All 6 versions

A bitter pill: formulary variability and the challenge to prescribing physicians

- jabfm.com
WH Shrank, SL Ettner, P Glassman, SM Asch - Journal of the American Board of Family Medicine, 2004 - Am Board Family Med
Methods: In 6 major health plans in California, we evaluated formulary incentive
variability in 4 of the 5 drug classes with the highest expenditures in
California: proton pump inhibitors, hydroxymethylglutaryl coenzyme A ...
Cited by 14 - Related articles - All 11 versions

[PDF] Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from …


WH Shrank, HN Young, SL Ettner, P Glassman … - Am J Manag Care, 2005 - ajmc.com
Over the last 5 years, 3-tier pharmaceutical ben- efit systems have become the
dominant phar- macy benefit structure in the United States.1 As recently as
1998, only 8% of Americans with prescrip- tion drug coverage were enrolled ...
Cited by 32 - Related articles - View as HTML - All 5 versions

The effect of pharmacy benefit design on patient-physician communication about costs

- nih.gov
WH Shrank, SA Fox, A Kirk, SL Ettner, CH … - Journal of general internal medicine, 2006 - Springer
William H. Shrank, MD, MSHS, 1,2 Sarah A. Fox, EdD, 5,6 Adele Kirk, MS, 5 Susan
L. Ettner, PhD, 5 ... Clairessa H. Cantrell, BA, 5,6 Peter Glassman, MBBS, MSc,
3,4,5 Steven M. Asch, MD, MPH 3,4,5
Cited by 29 - Related articles - BL Direct - All 9 versions

[CITATION] Prescription Drug Trends [fact sheet]. November 2005


KF Foundation
Cited by 3 - Related articles

[CITATION] How Do Patterns of Prescription Drug Coverage and Use Differ for White, African American, …


KF Foundation
Cited by 3 - Related articles

[CITATION] Outpatient prescription drug expenses, 1999. Rockville, Md: Agency for Healthcare …


MN Stagnitti, GE Miller, JF Moeller
Cited by 3 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google